Zhejiang Xianju Pharmaceutical Co.,Ltd. (SHE:002332)
China flag China · Delayed Price · Currency is CNY
8.62
-0.10 (-1.15%)
May 20, 2026, 12:35 PM CST

SHE:002332 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
8,6268,9139,83312,63211,17813,058
Market Cap Growth
-5.01%-9.36%-22.16%13.01%-14.39%-1.20%
Enterprise Value
7,6017,9188,69311,20810,04612,828
Last Close Price
8.729.019.5211.9410.3511.90
PE Ratio
21.8119.8224.7622.4314.9221.08
Forward PE
18.3615.9415.9415.9415.9415.94
PS Ratio
2.352.372.463.062.553.00
PB Ratio
1.411.471.672.172.032.64
P/TBV Ratio
1.621.701.922.522.383.19
P/FCF Ratio
47.59232.0851.4635.0134.2131.90
P/OCF Ratio
23.7136.0124.6721.2118.3519.85
EV/Sales Ratio
2.072.112.172.722.292.94
EV/EBITDA Ratio
12.7212.3110.3813.7311.6014.97
EV/EBIT Ratio
19.9918.4614.0818.5314.8019.06
EV/FCF Ratio
41.94206.1745.5031.0630.7531.34
Debt / Equity Ratio
0.020.030.010.040.060.15
Debt / EBITDA Ratio
0.250.310.070.270.400.86
Debt / FCF Ratio
0.825.240.310.611.051.81
Net Debt / Equity Ratio
-0.17-0.16-0.22-0.25-0.25-0.21
Net Debt / EBITDA Ratio
-1.80-1.55-1.58-1.76-1.59-1.20
Net Debt / FCF Ratio
-5.89-25.90-6.92-3.99-4.21-2.51
Asset Turnover
0.510.530.570.600.650.64
Inventory Turnover
1.561.621.882.172.072.26
Quick Ratio
2.372.232.942.292.581.83
Current Ratio
3.323.154.203.253.542.57
Return on Equity (ROE)
6.64%7.56%6.83%9.92%14.29%13.04%
Return on Assets (ROA)
3.30%3.76%5.52%5.51%6.30%6.20%
Return on Invested Capital (ROIC)
6.24%7.51%11.07%12.44%14.45%14.79%
Return on Capital Employed (ROCE)
6.10%6.90%9.90%10.20%11.80%12.60%
Earnings Yield
4.63%5.04%4.04%4.46%6.70%4.74%
FCF Yield
2.10%0.43%1.94%2.86%2.92%3.14%
Dividend Yield
4.59%3.33%3.15%2.51%2.90%1.26%
Payout Ratio
100.67%89.30%75.08%53.24%20.58%27.79%
Buyback Yield / Dilution
-0.64%-0.63%-0.51%0.13%-0.00%-7.84%
Total Shareholder Return
3.95%2.70%2.64%2.65%2.90%-6.58%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.